Transcript Document

Welcome
Community College Program
Annual Community College Program Day
Organizing Committee
Sonia Wallman – Executive Director NBC2
Elaine Johnson – Bio-Link Director
Russ Read – National Center, NC BioNetwork
Lance Hartford – MassBioEd Foundation
Margaret Bryans – PI NBC2, Montgomery County
Community College
• Lisa Seidman – Madison Area Technical College
• Tim Dubuque - NBC2
•
•
•
•
•
Massachusetts BioPharma Employment
Continues Growth
The industry
weathered
the 2009
downturn
without an
employment
drop.
53%
Growth
since
2002
Source: U.S. Census, County Business Patterns and MassBio formula and analysis.
*2011 figure is a preliminary estimate based on review of Massachusetts ES-202 data for 2010-2011.
Biotechnology R&D Employment
According to the
Bureau of Labor
Statistics’
Quarterly Census
of Employment &
Wage (QCEW)
data,
Massachusetts
leads the nation
in biotechnology
research &
development
employment.
CA
CT
MA
MD
MI
MO
NJ
NY
NC
PA
WA
2007
19,134
2,452
24,565
10,154
4,670
4,262
8,567
2,679
7,042
15,902
2,499
2010
21,616
1,582
26,807
9,469
2,759
3,874
9,224
3,553
6,275
12,776
3,730
Source: U.S. Bureau of Labor Statistics, Quarterly Census of Employment and Wages (QCEW)
Drug Development Pipeline, August 2011
Candidate medicines of Massachusetts-headquartered* companies, by clinical trials
stage
Massachusettsheadquartered
companies*
account for about
10% of the U.S.
drug development
pipeline and 5%
of the global
pipeline.
Pre-Clinical
316
Phase I
216
Phase II
275
Phase III
76
Pending Approval
14
Massachusetts-headquartered companies’ share of U.S. and Global drug
development pipeline
% of US
% of Global
Total Trials
9.41%
4.91%
PC
11.00%
5.88%
I
11.99%
6.43%
II
8.26%
4.56%
III
8.46%
3.52%
PA
3.89%
1.44%
* There are many drugs in development in Massachusetts by companies with headquarters
located outside of Massachusetts. These candidate drugs are not included in any
Massachusetts pipeline estimates found in this report.
Source: MedTrack Online, Life Sciences Analytics, Inc.
Massachusetts Pipeline by Therapeutic Area
Of the 897 drugs in
the Massachusetts
pipeline, 42.7%
are cancer drugs.
Drugs intended for
the Central
Nervous System
(CNS) therapeutic
area are next at
10.1% of the
pipeline.
Cancer
Central Nervous System
Infectious
Autoimmune and Inflammation
Metabolic/Endocrinology
Ophthalmology and Optometry
Respiratory and Pulmonary System
Blood and Lymphatic System
Cardiovascular & Circulatory
Musculo-Skeletal-Disorders
Digestive
Dermotology
Kidney & Genito-Urinary
Genetic Diseases & Dysmorphic Syndromes
Substance Abuse
Women's Health
Miscellaneous
Total Trials Companies
383
59
91
35
84
30
61
33
47
23
32
13
32
20
30
16
25
36
24
11
19
15
18
15
13
10
11
6
10
5
9
6
8
7
Source: MedTrack Online, Life Sciences Analytics, Inc.
Venture Capital Investment
$1.071 billion
invested in MA
biotechs in 2011
is an historic
high.
$8.054
billion since
2002
Source Data: 2011 PricewaterhouseCoopers, National Venture Capital Association, MoneyTreeTM Report, Historical Trend Data, and MassBio
analysis.
MA Share of the Biotech VC Dollar
MA biotechs
received 22.6%
of all VC biotech
financing, just
below the 2010
all-time high.
Source: 2011 PricewaterhouseCoopers, National Venture Capital Association,
MoneyTreeTM Report, Historical Trend Data, MassBio analysis.
Leading BioPharma Employers (MA), 2011
MA has benefited
from the pharma
industry’s
embrace of
biotechnology.
1. Genzyme (Sanofi)
2. Pfizer
3. Biogen Idec
4. Novartis
5. Thermo Fisher Scientific
6. Shire
7. Vertex
8. EMD Millipore
9. Parexel International
10. Millenium: Takeda Oncology
11. Charles River Laboratories
12. AstraZeneca
13. EMD Serono
14. Hologic
15. Abbott Laboratories
16. Sunovion Pharmaceuticals (DSP)
17. Nova Biomedical
18. Cubist
19. Lantheus
19. Merck
20. Bristol-Myers Squibb
4,356
2,600
2,300
2,100
1,700
1,500
1,310
1,237
1,200
1,050
970
900
850
800
750
690
631
626
550
330
320
Sources: MassBio, membership reports, survey, Boston Business Journal Book of Lists, 2011.
Mass Biomanufacturing
Of the top 11
biopharma
manufacturing
states,
Massachusetts
was one of just
four which added
manufacturing
jobs in the last
decade
BioPharma Industry Impact in MA
The estimated
average
salary in the
biopharma
industry is
77% higher
than the
estimated
state average
salary of
$53,834.
$4,615,364,513 in payroll (2010)
$95,628 in average salary (2010)
Source: U.S. Census, County Business Patterns, MassBio estimate using 2009 base data .
Massachusetts Exports, 2010
All Commodities
Optic, Photo Etc, Medic Or Surgical Instrments Etc
Industrial Machinery, Including Computers
Electric Machinery Etc; Sound Equip; Tv Equip; Pts
Pharmaceutical Products
26,256,370,201
5,324,511,940
4,601,715,086
4,518,662,880
2,136,306,456
20.20%
8.10%
Source: MassExport Center
Why Massachusetts?
500+
430+
Biopharma
Biotech
Companies
Top 5
Top
5
122
NIH funded
NIH funded
Research
Research
Hospitals
Hospitals
Colleges &
Universities
1st in
1st in
Venture Capital
& federal
SBIR funds
research
per worker
funds
per worker
Education
Level of
workforce (US)
Workforce
Supportive
Local, State Government
Life Sciences Initiative
Biotech Caucus
The $1 Billion Massachusetts Life
Sciences Initiative
Over time, the
industry
demonstrated its
value,
commitment to
the region, and
promise for the
future . . . and
state government
responded.
• 10
years
• $1 billion
Investment
Education and Workforce Development
Initiatives
U.S. Department of Labor to receive the Trade Adjustment Assistance
Community College and Career Training Grant. $20M
The Metro Boston Skilled Careers in Life Sciences (SCILS) initiative $5M – Life
Sciences Center & Quincy College
Mass Life Science Center Internship Program - since the program first launched
in 2009, the Center has placed 794 interns at more than 250 companies
throughout Massachusetts!
MassBioEd Foundation’s industry endorsement of eight community college
programs
Northeast Biomanufacturers and
Community Colleges with Biomanufacturing